424 related articles for article (PubMed ID: 20399617)
1. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
Räsänen K; Vaheri A
J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
[TBL] [Abstract][Full Text] [Related]
2. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
Wilkins-Port CE; Higgins PJ
Cells Tissues Organs; 2007; 185(1-3):116-22. PubMed ID: 17587817
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
4. SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes.
Villar V; Kocic J; Bugarski D; Jovcic G; Santibanez JF
FEBS Lett; 2010 Nov; 584(22):4586-92. PubMed ID: 20965173
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
Liu X
Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition.
Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555
[TBL] [Abstract][Full Text] [Related]
9. VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.
Gonzalez-Moreno O; Lecanda J; Green JE; Segura V; Catena R; Serrano D; Calvo A
Exp Cell Res; 2010 Feb; 316(4):554-67. PubMed ID: 20006606
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].
Xu GP; Li QQ; Cao XX; Chen Q; Zhao ZH; Diao ZQ; Xu ZD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1918-23. PubMed ID: 17923018
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.
Lee EK; Jeon WK; Chae MY; Hong HY; Lee YS; Kim JH; Kwon JY; Kim BC; Park SH
Biochem Biophys Res Commun; 2010 Jan; 391(1):1021-7. PubMed ID: 19968960
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.
Zhang A; Wang MH; Dong Z; Yang T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1323-31. PubMed ID: 16868306
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism.
Yang Y; Pan X; Lei W; Wang J; Song J
Oncogene; 2006 Nov; 25(55):7235-44. PubMed ID: 16799646
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.
Chen CL; Chou KJ; Lee PT; Chen YS; Chang TY; Hsu CY; Huang WC; Chung HM; Fang HC
Exp Cell Res; 2010 Apr; 316(7):1109-18. PubMed ID: 20202468
[TBL] [Abstract][Full Text] [Related]
16. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
17. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
Maeda M; Johnson KR; Wheelock MJ
J Cell Sci; 2005 Mar; 118(Pt 5):873-87. PubMed ID: 15713751
[TBL] [Abstract][Full Text] [Related]
18. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
Lee HS; Kim C; Kim SB; Kim MG; Park D
Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells.
Xu Z; Shen MX; Ma DZ; Wang LY; Zha XL
Cell Res; 2003 Oct; 13(5):343-50. PubMed ID: 14672557
[TBL] [Abstract][Full Text] [Related]
20. Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells.
Mariasegaram M; Tesch GH; Verhardt S; Hurst L; Lan HY; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2010 Mar; 393(4):855-9. PubMed ID: 20171171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
